bibliographic entry 12414289 [be/12414289]
https://w3id.org/oc/corpus/be/12414289

is a

• bibliographic reference

content

• Motzer, R. J, Porta, C, Bjarnason, G. A, Szcylik, C, Rha, S. Y, Esteban, E, … Escudier, B. J. (2012). Phase III trial of dovitinib (TKI258) versus sorafenib in patients with metastatic renal cell carcinoma after failure of anti-angiogenic (VEGF-targeted and mTOR inhibitor) therapies. ASCO Meeting Abstracts, 30(15_suppl), TPS4683.

references

• https://w3id.org/oc/corpus/br/8212789